Adaptive Recruitment Curve Analysis Using Bayesian Modeling

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorColumbia University

About this trial

The purpose of this study is to better understand how electrical or magnetic stimulation affect the nervous system by optimizing the way researchers measure muscle responses. The relationship between stimulation intensity and muscle response is described by "neural recruitment curves," which are critical for monitoring the state of the nervous system during therapies like transcranial magnetic stimulation (TMS) and spinal cord stimulation (SCS).

This study tests a new, real-time computational approach based on our previously developed methods (Hierarchical Bayesian models) to estimate these recruitment curves more efficiently. The primary goal is to use this model to dynamically guide the experiment, automatically selecting the optimal stimulation intensities to test.

The investigators hypothesize that this optimized approach will accurately estimate the entire recruitment curve, or specific targets components of it like the motor threshold, using significantly fewer samples than standard methods. By reducing the number of measurements required, this approach aims to decrease experimental time and minimize participant burden, making future TMS and SCS therapies and experiments more feasible and efficient.

Eligibility criteria

Qualifiers

None

Disqualifiers

Presence of any neurological disorder

History of seizures

History of autonomic dysfunction

Current use of seizure-threshold lowering medications

Trial design

Treatments tested in this trial

  • Algorithm: Uniform Sampling
  • Algorithm: hbMEP-adaptive algorithm (version 1)
  • Algorithm: hbMEP-adaptive algorithm (version 2)
  • ML-PEST
  • MagPro X100 Transcranial Magnetic Stimulation
  • Digitimer DS8R Transcutaneous Electrical stimulation

Treatment groups

10 Participants
are divided into 1 treatment group

Sponsors and collaborators

Columbia University

Lead sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborator